Next Article in Journal
Antibiotic Resistance Related to Biofilm Formation in Klebsiella pneumoniae
Previous Article in Journal
Exploring Dangerous Connections between Klebsiella pneumoniae Biofilms and Healthcare-Associated Infections
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pathogens
Volume 3
Issue 3
10.3390/pathogens3030732
pathogens-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Genetic Characterization of Fungi Isolated from the Environmental Swabs collected from a Compounding Center Known to Cause Multistate Meningitis Outbreak in United States Using ITS Sequencing

by
Irshad M. Sulaiman
*,
Emily Jacobs
,
Steven Simpson
and
Khalil Kerdahi
Southeast Regional Laboratory, U.S. Food and Drug Administration, 60, Eighth Street NE, Atlanta, GA 30309, USA
*
Author to whom correspondence should be addressed.
Pathogens 2014, 3(3), 732-742; https://doi.org/10.3390/pathogens3030732
Submission received: 28 April 2014 / Revised: 31 July 2014 / Accepted: 19 August 2014 / Published: 22 August 2014
Versions Notes

Abstract

:
A multistate fungal meningitis outbreak started in September of 2012 which spread in 20 states of the United States. The outbreak has been fatal so far, and has affected 751 individuals with 64 deaths among those who received contaminated spinal injections manufactured by a Compounding Center located in Massachusetts. In a preliminary study, Food and Drug Administration (FDA) investigated the outbreak in collaboration with Centers for Disease Control and Prevention (CDC), state and local health departments, and identified four fungal and several bacterial contaminations in the recalled unopened injection vials. This follow-up study was carried out to assess DNA sequencing of the ITS1 region of rRNA gene for rapid identification of fungal pathogens during public health outbreak investigations. A total of 26 environmental swabs were collected from several locations at the manufacturing premises of the Compounding Center known to have caused the outbreak. The swab samples were initially examined by conventional microbiologic protocols and a wide range of fungal species were recovered. Species-identification of these microorganisms was accomplished by nucleotide sequencing of ITS1 region of rRNA gene. Analysis of data confirmed 14 additional fungal species in the swabs analyzed.

1. Introduction

The primary mission of the U.S. Food and Drug Administration (FDA) is to enforce the Food, Drug and Cosmetic Act and regulate food, drug and cosmetic products. To evaluate adulteration in these products, FDA uses the presence of fungi in manufacturing and distribution areas as one of the regulatory action criteria and also to ensure that the firm is following good manufacturing practices (GMP). One way to achieve the said goal is establishing an environmental monitoring program, and verifying the effectiveness of pathogen control in the production as well as distribution areas where the food, drug or cosmetics are exposed to potential contaminants. The environmental monitoring program provides significant information on the quality of the aseptic processing environment when a given batch of food, drug or cosmetic is being manufactured together with environmental trends of the manufacturing area. A proper monitoring program also identifies potential routes of contamination, allowing for implementation of corrections before product contamination occurs [1].
A multistate fungal meningitis outbreak started in mid-September of 2012. This outbreak affected individuals who had received contaminated injections (that included betamethasone, cardioplegia, and triamcinolone solutions), manufactured and distributed by a Compounding Center located in Massachusetts to outpatient facilities in 20 states of the United States. The firm voluntarily terminated all operations, surrendered its license, and announced a recall of all their products on October 3, 2012. In the beginning, FDA investigated this outbreak in collaboration with U.S. Centers for Disease Control and Prevention (CDC), state and local health departments, and analyzed the unopened vials of spinal injections. Four fungal (including Aspergillus tubingensis, Aspergillus fumigatus, Cladosporium sp., and Penicillium sp.) and several bacterial contaminations (Bacillus circulans, Bacillus firmus, Bacillus flexus, Bacillus halmapalus/horikoshii, Bacillus idriensis, Bacillus lentus, Bacillus niabensis, Bacillus niacini, Bacillus nealsonii, Bacillus pumilus, Bacillus simplex, Bacillus subtilis group, Brevibacillus choshinensis, Kocuria rosea, Lysinibacillus sp., Paenibacillus barengoltzii/timonensis, Paenibacillus pabuli/amolyticus,) were identified in the recalled unopened vials shipped by this Compounding Center [2,3,4]. Later, while analyzing the tissue and human fluids of patients infected with above contaminated injections CDC confirmed Exserohilum rostratum as the predominant fungal infection in this outbreak, and identified 22 additional fungal species (including Aspergillus sp., Cladosporium sp., Alternaria sp., Bipolaris sp., Chaetomium sp., coelomycete fungus, Epicoccum nigrum, Paecilomyces, Penicillium sp., Scopulariopsis brevicaulis, and Stachybotrys chartarum). Furthermore, CDC was able to isolate four more fungal species (Cladosporium cladosporioides, Exserohilum rostratum, Rhodotorula laryngis and Rhizopus stolonifer) from some of the unopened vials examined. The outbreak was deadly and affected a total of 751 individuals resulting in 64 deaths, as of October 23, 2013 [4].
To date, the taxonomy of fungi is in a constant state of flux. The kingdom fungi have been estimated to be approximately 1.5–5 million species that grow as hyphae, with about 5% of these having been formally classified. The 200,000 known fungal species make up a quarter of the biomass of the earth. Of these, approximately 100,000 genera have been identified as the mold species, and 80 of them are known to cause illness in humans. In recent years, DNA based molecular characterizations of fungi have been extremely successful to understand the extents of genetic diversity at inter- and intra- species level. Phylogenetic studies have further revealed a monophyletic origin of fungi with a closer relationship to animals than plants. Of various genetic marker characterized, the internal transcribed spacer (ITS) region of rRNA gene has been most widely sequenced in fungi [5,6,7]. More recently, the ITS region was also proposed as the universal DNA barcode marker for fungal taxonomy and species identification [8].
This follow-up study was conducted to determine a possible cause of the multistate fungal meningitis outbreak. To achieve the goal, 26 environmental swab samples were collected from various locations of the manufacturing premises of the compounding company following the guidelines of FDA. These swabs were examined for the presence of fungal species initially by conventional microbiologic protocols. Afterwards, the recovered fungal isolates were genetically identified by performing DNA sequencing of PCR-amplified ITS1 region of rRNA gene. Species-specific variation was obtained based on ITS1 sequence characterization. Results of study clearly indicated the ITS1 region to be a consistent genetic marker for rapid detection and differentiation of human-pathogenic fungi, considered as microbiological indicators in the environment of public health importance.

2. Results and Discussion

2.1. Recovery of Fungal Isolates from Environmental Swab Samples using Selective Enrichment Media

Of the 26 swab samples examined, fungal isolates were recovered from 25 of the swabs from both liquid (Sabouraud Dextrose Broth) and semi-solid (Malt Extract Agar) selective media. These media are widely used for the determination of fungistatic activity and cultivation of pathogenic fungi from food, pharmaceutical and cosmetic products (sterile and non-sterile) and in performing Environmental Monitoring and Sterility Testing [9,10].

2.2. Genetic Diversity of Recovered Fungal Species from Environmental Swabs at the ITS Locus

Genomic DNA was extracted and used to amplify the ITS1 region of rRNA gene, for all of the 25 recovered fungal isolates from the environmental swab samples. Nucleotide sequence of ITS1 region of rRNA gene was obtained for all 25 recovered isolates by performing bi-directional sequencing of the PCR amplified fragments. DNA sequences from both forward and reverse primers were assembled, manually edited and compared with the known sequences available in the GenBank using BLAST algorithm. The PCR was repeated and the resultant PCR products were sequenced again when the sequence data was obtained with low quality score. The DNA sequences were considered identical if they shared 100% identity with the known ITS1 sequences available in GenBank. A species-specific genetic variation was observed in the ITS1 region of rRNA gene characterized. However, the intra-specific genetic variation was not noticed at this locus.
Multiple alignments of the generated ITS1 region of rRNA nucleotide sequences confirmed the presence of 14 distinct fungal species belonging to 12 different genus that included Alternaria alternata, Alternaria tenuissima, Aspergillus niger, Aureobasidium pullans, Aureobasidium proteae, Chaetomium globosum, Cryptococcus saitoi, Filobasidium capsuligenum, Leptosphaerulina chartarum, Mucor racemosus, Mucor velutinosus, Penicillium chrysogenum, Rhizomucor variabilis, Rhizopus oryzae, and Rhodotorula glutinis (Table 1).
Table
Table 1. Species-specific identification of fungal isolates recovered from environmental swabs collected from the Compounding Company premises by sequence characterization of ITS1 region of rRNA gene.
Table 1. Species-specific identification of fungal isolates recovered from environmental swabs collected from the Compounding Company premises by sequence characterization of ITS1 region of rRNA gene.
Species IdentifiedSwab Sample AnalyzedSequence Type% Similarity (bp)*Reference
Alternaria alternataES-24rRNA100 (246)KC568287, this study
Alternaria tenuissimaES-4rRNA100 (211)JX867219, this study
Aspergillus nigerES-8rRNA100 (268)KC119204, this study
Aureobasidium proteaeES-13rRNA100 (229)JN712490, this study
Aureobasidium pullulansES-22rRNA100 (221)AY139394, this study
Chaetomium globosumES-9rRNA100 (210)JX406510, this study
Chaetomium globosumES-18rRNA100 (256)AY429056, this study
Chaetomium globosumES-19rRNA100 (256)AY429056, this study
Chaetomium globosumES-20rRNA100 (256)AY429056, this study
Cryptococcus saitoiES-25rRNA100 (245)KC254024, this study
Filobasidium capsuligenumES-16rRNA100 (214)EF532832, this study
Leptosphaerulina chartarumES-5rRNA100 (299)JX442978, this study
Leptosphaerulina chartarumES-21rRNA100 (291)EU272493, this study
Mucor racemosusES-10rRNA100 (290)AY213660, this study
Mucor racemosusES-11rRNA100 (290)AY213660, this study
Mucor racemosusES-12rRNA100 (290)AY213660, this study
Mucor racemosusES-23rRNA99 (289)AY213660, this study
Mucor velutinosusES-1rRNA100 (279)JX120704, this study
Mucor velutinosusES-2rRNA100 (279)JX120704, this study
Mucor velutinosusES-3rRNA100 (279)JX120704, this study
Penicillium chrysogenumES-6rRNA100 (211)JF807949, this study
Penicillium chrysogenumES-7rRNA100 (211)JF807949, this study
Rhizomucor variabilisES-17rRNA100 (253)JF904893, this study
Rhizopus oryzaeES-14rRNA100 (239)JN227043, this study
Rhodotorula glutinisES-26rRNA100 (220)JQ993380, this study
*Representative sequences generated in this study have been deposited in GenBank, with accession numbers KC852046 to KC8522066, and KF445073 to KF445076.
The engendered DNA sequences belonging to ITS1 region of rRNA gene of all the isolated fungal species except one isolate matched 100% with the published sequences available in the GenBank. The recovered isolate MOSS23 (M. racemosus) displayed single nucleotide mutation at position 153 (“G” to “A”) as compared to several existing DNA sequences in the public domain of this species (GenBank accession no. JF440624, GenBank accession no. AY213660).

2.3. DNA Sequencing of ITS region in Molecular Typing of Human-pathogenic Microorganisms

Molecular genetic characterization of microorganisms has been extensively exploited for rapid detection and differentiation of a human-pathogenic species from sporadic cases, surveillance and outbreak samples of public health importance. These tools have provided correct identification of responsible infectious species, and helped in conducting epidemiologic investigations to determine the transmission routes. The rRNA genes are the most abundant housekeeping genes present in all organisms often with several copies evolving at a slower evolutionary rate [11,12]. Thus, this locus has been extensively used as the genetic marker to understand the phylogenetic relationship, and in developing diagnostic assays for rapid detection and differentiation of pathogenic species and their vectors [13,14,15,16,17].
Fungi encompass the second largest kingdom of eukaryotes that include human-pathogenic yeast and molds as well. Therefore, finding a suitable genetic marker for fungal taxonomy has been a daunting task. Although a number of genes have been typed as a genetic marker, the ITS1 region of rRNA gene has been the most recognized locus for species identification and sub-generic phylogenetic relationship in fungi. However, the ITS2 region of rRNA region has also been exploited for above purposes [5,6,7,18,19,20,21,22,23]. In a recent comprehensive study, ITS locus is recommended as the universal DNA barcode marker for fungi [8]. The ITS1 sequence characterization of ITS1 regions has identified 40 species of human-pathogenic yeasts [6]. ITS based multiplex PCR assay identified five Rhizopus species including Rhizopus oryzae that causes meningitis in humans [21]. The ITS locus also revealed phylogenetically valid information for correct identification of 201 strains of clinically important molds belonging to 44 different species, while performing multilocus DNA sequence comparisons [24]. The ITS region of Rhizopus microspores was also utilized as a marker in an outbreak investigation of intestinal mucormycosis infection [25]. More recently, the ITS region (~350 bp) was also exploited for performing the targeted PCR and DNA sequencing in the detection of fungal DNA in clinical samples (human body fluids and tissues) during the investigation of this multistate outbreak of fungal meningitis and other infections. Using this genetic marker, Exserohilum rostratum DNA was detected and confirmed in 123 samples from the 114 case-patients, and Cladosporium sp. DNA in one sample from one case-patient [4].

2.4. Public Health Significance of the Presence of Fungi in Environment

In this study, we discovered fungi in 96% of the 26 environmental swab samples examined from the premises of the Compounding Company located in Massachusetts, and performed sequencing for these recovered isolates at the ITS1 region of rRNA locus. Analysis of data of the generated ITS1 region of rRNA gene sequences confirmed the presence of 14 distinct fungal species belonging to 12 different genera among the 26 swabs analyzed. Majority of the recovered fungal species from swabs (this study) have been reported to thrive in damp places (home or environment), and thus their presence is considered an indicator of moist and humid conditions. Several of the recovered fungal species such as Chaetomium globosum were reported to grow successively in water damaged buildings especially when they occur due to leakage through roofs and defective plumbing installations. In a study focusing on potential health effects of fungal exposure in the indoor environments, an extensive ITS sequencing was employed to characterize and compare the fungal flora isolated from the indoor dust collected from two nonindustrial buildings; one of the buildings was moisture damaged and the other was undamaged [22].
The presence of fungal species has been considered as environmental microbiological indicators [26]. Furthermore, some of the recovered fungi (this study) have been described to cause cutaneous and respiratory infections, and chronic fungal meningitis in humans that include several species belonging to Alternaria, Aspergillus, Aureobasidium, Chaetomium, Mucor and Penicillium genera [27,28,29,30,31,32]. In addition, fungi are known to initiate three major environmental conditions that include: (i) structural integrity of a building, (ii) negative aesthetic effects i.e. unpleasant to live in a building due to its look and foul odor, and (3) adverse health effects in sensitive individuals [33,34]. Fungi have also been used as biological indicators for measuring the indoor air quality of a building, and its impact on the health and well-being of inhabiting humans [35].
While comparing the results obtained from this study on characterization of the environmental swabs collected from the premises of the Compounding Company that was involved in manufacturing infected injections, it is important to mention that four fungal species were (Aspergillus tubingensis, Aspergillus fumigatus, Cladosporium species, and Penicillium species) isolated from the same lot of unopened vials of infected injections that caused the multistate fungal meningitis outbreak, in an earlier study carried out by FDA [4]. In addition, CDC identified 22 additional fungal species (Aspergillus sp., Alternaria sp., Bipolaris sp., Chaetomium sp., Cladosporium sp., coelomycete fungus, Epicoccum nigrum, Exserohilum rostratum, Paecilomyces, Penicillium sp., Scopulariopsis brevicaulis, and Stachybotrys chartarum with Exserohilum rostratum as the most prevalent species) in the infected patients, and four fungal species (Cladosporium cladosporioides, Exserohilum rostratum, Rhodotorula laryngis and Rhizopus stolonifer) in the unopened vials [4]. Of the 14 distinct fungal species (Alternaria alternata, Alternaria tenuissima, Aspergillus niger, Aureobasidium pullans, Aureobasidium proteae, Chaetomium globosum, Cryptococcus saitoi, Filobasidium capsuligenum, Leptosphaerulina chartarum, Mucor racemosus, Mucor velutinosus, Penicillium chrysogenum, Rhizomucor variabilis, Rhizopus oryzae, and Rhodotorula glutinis) recovered from the environmental swab samples in this study, some the fungal species were also recovered earlier in the unopened vials (such as Aspergillus sp., Penicillium sp. Rhizopus sp., and Rhodotorula sp.) as well as in the infected patients (Aspergillus sp., Alternaria sp., Chaetomium sp., and Penicillium sp.). Exserohilum rostratum was not recovered from the environmental swabs examined.
Recovering a large number of fungal species in the environmental swab samples analyzed in this study may be explained as the initial inspection carried out at the Compounding Company premises revealed that: (i) the firm’s environmental monitoring program yielded microbial isolates (bacteria and mold) within the clean room 1 and clean room 2 used for the production of sterile drug products between January 2012 and September 2012, and (ii) the firm was shutting off the air conditioning from 8:00 pm to 5:30 am in these clean rooms [4].

3. Experimental Section

3.1. Environmental Swab Sample Characterization and Recovery of Fungal Isolates

To recover fungi from the 26 environmental swabs, each swab was placed in a sterile plastic bag containing 100 mL of sterile Sabouraud Dextrose Broth (BD DifcoTM, Sparks, MD, USA), and incubated at 25 °C for 5 days. After completion of 5 days of incubation, the broth was streaked to Malt Extract Agar (BD DifcoTM) plates, and incubated at 25 °C for additional 7 days. These plates were read and growth was recorded after 24 h intervals every day for the next 7 days. Fungi observed on any of the agar plates were examined by staining and microscopy initially. Afterward, the recovered isolates were genetically characterized at molecular level for species identification. An unopened sterile swab was also tested as negative control. Furthermore, Candida albicans (ATCC #10231) and Aspergillus brasilensis (ATCC #16404) cultures were carried through the analysis to serve as positive culture controls. The swabbing was done on critical contact surfaces (with product and container) that included biological safety cabinet, equipment surfaces, and floors and walls of clean room of the manufacturing premises.

3.2. DNA Extraction

For genomic DNA extraction, a small portion (<100 mg) of fungal specimen was homogenized using a clean and autoclaved mortar and pestle, if needed liquid nitrogen was used. The homogenate was purified by RNeasy Plant Mini Kit DNA, following manufacturer’s protocol and recommendations for the purification of total genomic DNA from fungi (QIAGEN, Valencia, CA, USA). The concentration of purified DNA samples was measured at 260-nm absorbance using a NanoDrop-1000 spectrophotometer (NanoDrop Technology, Rockland, DE), and stored at –20 °C until used.

3.3. PCR Amplification

To amplify the fragments of ITS1 region of rRNA gene, a previously described forward (5'-TCC GTA GGT GAA CCT GCG G-3') and reverse (5'-GCT GCG TTC TTC ATC GAT GC-3') primer set [6,18,36] was used, with modifications in PCR conditions. For PCR, a total of 50 µL PCR reaction consisted of 25 µL of HotStarTaq Master Mix (QIAGEN), and 25 µL of a solution containing 200 nM of each primer, 1.5 mM of additional MgCl2 (Promega, Madison, WI, USA) and template DNA (50 ng) diluted in PCR grade water. The QIAGEN HotStarTaq Master Mix is a premixed solution containing HotStarTaq DNA Polymerase, PCR Buffer, and dNTPs with a final concentration of 1.5 mM MgCl2 and 200 µM each dNTP. The PCR reactions were run for 35 cycles (each cycle is 94 °C for 45 s, 55 °C for 45 s, and 72 °C for 60 s) in a GeneAmp PCR 9700 thermocycler (Applied Biosystems, Foster City, CA, USA), with an initial hot start (94 °C for 15 min) and a final extension (72 °C for 10 min). The PCR products were analyzed by agarose gel electrophoresis, and visualized after ethidium bromide staining.

3.4. DNA Sequencing

The amplified PCR products were enzymatically cleaned before cycle sequencing, 3 μL of ExoSAP‐IT (USB Corporation, Cleveland, OH, USA) was added to 5μL of each amplified PCR product. The mixture was incubated at 37 °C for 20 min followed by 80 °C for 15 min on a GeneAmp PCR 9700 thermocycler (Applied Biosystems). The purified PCR products were sequenced using AB Big-Dye 3.1 dye chemistry and AB 3500 XL automated DNA sequencers (Applied Biosystems) with sequencing reaction competed for 25 cycles (each cycle is 96 °C for 30 s, 50 °C for 15 s, and 60 °C for 4 min) and hold at 4 °C in a GeneAmp PCR 9700 thermocycler (Applied Biosystems). The cycle sequencing reactions contained 2 μL of cleaned PCR product, 1 μL of BigDye Terminator v3.1 Ready Reaction Mix, 2 μL of 5× Sequencing Buffer, 1.6 pmol of Forward or Reverse sequencing primer, and water in a final volume of 20 μL. Sequencing reactions were cleaned up with the Performa® DTR Gel Filtration Cartridges following manufacturer’s protocol (Edge Bio, Gaithersburg, MD, USA).

3.5. Data Analysis

The accuracy of nucleotide sequence was confirmed by performing two-directional sequencing, and by sequencing of a new PCR product if necessary. Multiple alignments of the nucleotide sequences were accomplished by BioEdit and Geneious programs with manual adjustments. The generated nucleotide sequences of ITS1 region of rRNA gene of recovered fungal species were deposited in GenBank database under accession number KC852046 to KC8522066, and KF445073 to KF445076.

4. Conclusions

Sequence characterization of the ITS1 locus can be used for the detection and differentiation of fungi from the environmental swab samples. This communication also reports for the first time the presence of 14 indicator fungal species isolated from the environmental swabs collected from the Compounding Center who previously manufactured the methylprednisolone injections contaminated with molds [2,3]. DNA sequencing of the ITS1 region of rRNA gene can be used for rapid identification of fungal pathogens during outbreak investigations of public health importance.

Acknowledgments

The findings and conclusions in this report are those of the authors and do not necessarily represent the views or official position of the U.S. Food and Drug Administration or the U.S. Department of Health and Human Services. Thanks are due to Ms. Lacresha Chatman and Ms. LaKenya Patton, Microbiological Sciences Branch, Southeast Regional Laboratory, FDA for their technical assistance. Thanks are also due to Ms. Nicky Sulaiman, Division of Scientific Resources, CDC, for her comments on the manuscript.

Author Contributions

Conceived and designed the experiments: Irshad M. Sulaiman. Performed the experiments: Emily Jacobs. Supervised DNA sequencing and other lab work: Irshad M. Sulaiman. Analyzed the data: Irshad M. Sulaiman. Contributed reagents/materials/analysis tools: Steven Simpson, Khalil Kerdahi. Wrote the manuscript: Irshad M. Sulaiman.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Food and Drug Administration. Federal Food, Drug, and Cosmetic Act. As Amended through December 31, 2004; U.S. Department of Health and Human Services, Government Printing Office: Washington, DC, USA, 2004. [Google Scholar]
  2. Centers for Disease Control and Prevention. Multistate outbreak of fungal infection associated with injection of methylprednisolone acetate solution from a single compounding pharmacy - United States, 2012. MMWR 2012, 61, 839–842. [Google Scholar]
  3. Kauffman, C.A.; Pappas, P.G.; Patterson, T.F. Fungal infections associated with contaminated methylprednisolone injections. New Eng. J. Med. 2013, 368, 2495–2500. [Google Scholar] [CrossRef] [PubMed]
  4. Multistate Outbreak of Fungal Meningitis and Other Infections. Available online: http://www.fda.gov/Drugs/DrugSafety/FungalMeningitis/default.htm and http://www.cdc.gov/hai/outbreaks/meningitis.html; (accessed on 21 August 2014).
  5. Guarro, J.; Gene, J.; Stchigel, A.M. Developments in Fungal Taxonomy. Clin. Microbiol. Rev. 1999, 12, 454–500. [Google Scholar] [PubMed]
  6. Chen, Y.C.; Eisner, J.D.; Kattar, M.M.; Rassoulian-Barrett, S.L.; Lafe, K.; Bui, U.; Limaye, A.P.; Cookson, B.T. Polymorphic internal transcribed spacer region 1 DNA sequences identify medically important yeasts. J. Clin. Microbiol. 2001, 39, 4042–4051. [Google Scholar] [CrossRef] [PubMed]
  7. Nilsson, R.H.; Kristiansson, E.; Ryberg, M.; Hallenberg, N.; Larsson, K. Intraspecific ITS Variability in the Kingdom Fungi as Expressed in the International Sequence Databases and Its Implications for Molecular Species Identification. Evol. Bioinform. Online 2008, 4, 193–201. [Google Scholar]
  8. Schoch, C.L.; Seifert, K.A.; Huhndorf, S.; Robert, V.; Spouge, J.L.; Levesque, C.A.; Chen, W. Fungal Barcoding Consortium. Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi. Proc. Nat. Acad. Sci. USA 2012, 109, 6241–6246. [Google Scholar]
  9. FDA’s Bacteriological Analytical Manual (BAM). Available online: http://www.fda.gov/Food/FoodScienceResearch/LaboratoryMethods/ucm2006949.htm (accessed on 21 August 2014).
  10. Murray, P.R.; Baron, J.H.; Pfaller, M.A.; Jorgensen, J.H.; Yolken, R.H. (Eds.) Manual of Clinical Microbiology, 8th ed.; American Society for Microbiology: Washington, DC, USA, 2003.
  11. Xiao, L.; Escalante, L.; Yang, C.; Sulaiman, I.M.; Escalante, A.A.; Montali, R.; Fayer, R.; Lal, A.A. Phylogenetic analyses of Cryptosporidium parasites based on small subunit ribosomal RNA gene locus. Appl. Env. Microbiol. 1999, 65, 1578–1583. [Google Scholar]
  12. Sulaiman, I.M.; Bern, C.; Gilman, R.H.; Cama, V.; Kawai, V.; Vargas, D.; Ticona, E.; Vivar, A.; Xiao, L. A molecular biologic study of Enterocytozoon bieneusi in HIV-infected patients in Lima, Peru. J. Euk. Microbiol. 2003, 50, 591–596. [Google Scholar] [CrossRef] [PubMed]
  13. Sulaiman, I.M.; Fayer, R.; Lal, A.A.; Trout, J.M.; Schaefer, F.W.; Xiao, L. Molecular characterization of microsporidia indicates that wild mammals harbor host-adapted Enterocytozoon spp. as well as human pathogenic Enterocytozoon bieneusi. Appl. Env. Microbiol. 2003, 69, 4495–4501. [Google Scholar]
  14. Sulaiman, I.M.; Fayer, R.; Yang, C.; Santin, M.; Matos, O.; Xiao, L. Molecular characterization of Enterocytozoon bieneusi in cattle indicates that only some isolate have zoonotic potentials. Parasitol. Res. 2004, 93, 328–334. [Google Scholar] [CrossRef] [PubMed]
  15. Sulaiman, I.M.; Anderson, M.; Khristova, K.; Tang, K.; Sulaiman, N.; Phifer, E.; Simpson, S.; Kerdahi, K. Development of a PCR-RFLP protocol for rapid detection and differentiation of four cockroach vectors (Group I “Dirty 22” Species) responsible for food contamination and spreading of foodborne pathogens: A public health importance. J. Food Protec. 2011, 74, 1883–1890. [Google Scholar] [CrossRef]
  16. Sulaiman, I.M.; Anderson, M.; Oi, D.H.; Simpson, S.; Kerdahi, K. Multilocus genetic characterization of two ant vectors (Group II “Dirty 22” species) known to contaminate food and food products and spread foodborne pathogens. J. Food Protec. 2012, 75, 1447–1452. [Google Scholar]
  17. Sulaiman, I.M.; Ortega, Y.; Simpson, S.; Kerdahi, K. Genetic characterization of human-pathogenic Cyclospora cayetanensis parasites from three endemic regions at the 18S ribosomal RNA locus. Infec. Genet. Evol. 2014, 22, 229–234. [Google Scholar] [CrossRef]
  18. Lott, T.J.; Kuykendall, R.J.; Reiss, E. Nucleotide sequence analysis of the 5.8S rDNA and adjacent ITS2 region of Candida albicans and related species. Yeast 1993, 9, 1199–1206. [Google Scholar]
  19. Voigt, K.; Cigelnik, E.; O’donnell, K. Phylogeny and PCR identification of clinically important Zygomycetes based on nuclear ribosomal-DNA sequence data. J. Clin. Microbiol. 1999, 37, 3957–3964. [Google Scholar] [PubMed]
  20. Chen, Y.C.; Eisner, J.D.; Kattar, M.M.; Rassoulian-Barrett, S.L.; Lafe, K.; Yarfitz, S.L.; Limaye, A.P.; Cookson, B.T. Identification of medically important yeasts using PCR-based detection of DNA sequence polymorphisms in the internal transcribed spacer 2 region of the rRNA genes. J. Clin. Microbiol. 2000, 38, 2302–2310. [Google Scholar] [PubMed]
  21. Nagao, K.; Ota, T.; Tanikawa, A.; Takae, Y.; Mori, T.; Udagawa, S.; Nishikawa, T. Genetic identification and detection of human pathogenic Rhizopus species; a major mucormycosis agent, by multiplex PCR based on internal transcribed spacer region of rRNA gene. J. Dermatol. Sci. 2005, 39, 23–31. [Google Scholar] [CrossRef] [PubMed]
  22. Pitkäranta, M.; Meklin, T.; Hyvärinen, A.; Paulin, L.; Auvinen, P.; Nevalainen, A.; Rintala, H. Analysis of fungal flora in indoor dust by ribosomal DNA sequence analysis, quantitative PCR, and culture. Appl. Env. Microbiol. 2008, 74, 233–244. [Google Scholar]
  23. Zhao, Z.; Li, L.; Wan, Z.; Chen, W.; Liu, H.; Li, R. Simultaneous detection and identification of Aspergillus and mucorales species in tissues collected from patients with fungal rhinosinusitis. J. Clin. Microbiol. 2011, 49, 1501–1507. [Google Scholar] [CrossRef] [PubMed]
  24. Rakeman, J.L.; Bui, U.; LaFe, K.; Chen, Y.; Honeycutt, R.J.; Cookson, B.T. Multilocus DNA Sequence Comparisons Rapidly Identify Pathogenic Molds. J. Clin. Microbiol. 2005, 43, 3324–3333. [Google Scholar] [CrossRef] [PubMed]
  25. Woo, P.C.; Leung, S.Y.; To, K.K.; Chan, J.F.; Ngan, A.H.; Cheng, V.C.; Lau, S.K.; Yuen, K.Y. Internal transcribed spacer region sequence heterogeneity in Rhizopus microsporus: Implications for molecular diagnosis in clinical microbiology laboratories. J. Clin. Microbiol. 2010, 48, 208–214. [Google Scholar] [CrossRef] [PubMed]
  26. Mendes, B.; Urbano, P.; Alves, C.; Morais, J.; Lapa, N.; Oliveira, J.S. Fungi as environmental microbiological indicators. Water Sci. Technol. 1998, 38, 155–162. [Google Scholar] [CrossRef]
  27. Blyth, W.; Grant, I.W.; Blackadder, E.S.; Greenberg, M. Fungal antigens as a source of sensitization and respiratory disease in Scottish malt workers. Clin. Allergy 1977, 7, 549–562. [Google Scholar] [CrossRef]
  28. Romano, C.; Valenti, L.; Miracco, C.; Alessandrini, C.; Paccagnini, E.; Faggi, E.; Difonzo, E.M. Two cases of cutaneous phaeohyphomycosis by Alternaria alternata and Alternaria tenuissima. Mycopathologia 1997, 137, 65–74. [Google Scholar] [CrossRef] [PubMed]
  29. Reiss, E.; Tanaka, K.; Bruker, G.; Chazalet, V.; Coleman, D.; Debeaupuis, J.P.; Hanazawa, R.; Latgé, J.P.; Lortholary, J.; Makimura, K.; et al. Molecular diagnosis and epidemiology of fungal infections. Med. Mycol. 1998, 36 (Suppl 1), 249–257. [Google Scholar]
  30. Paterson, P.J.; Seaton, S.; Yeghen, T.; McHugh, T.D.; McLaughlin, J.; Hoffbrand, A.V.; Kibbler, C.C. Molecular confirmation of invasive infection caused by Chaetomium globosum. Clin. Pathol. 2005, 58, 334–336. [Google Scholar]
  31. Alvarez, E.; Cano, J.; Stchigel, A.M.; Sutton, D.A.; Fothergill, A.W.; Salas, V.; Rinaldi, M.G.; Guarro, J. Two new species of Mucor from clinical samples. Med. Mycol. 2011, 49, 62–72. [Google Scholar] [CrossRef] [PubMed]
  32. Kutleša, M.; Mlinarić-Missoni, E.; Hatvani, L.; Voncina, D.; Simon, S.; Lepur, D.; Baršić, B. Chronic fungal meningitis caused by Aureobasidium proteae. Diag. Microbiol. Infec. Dis. 2012, 73, 271–272. [Google Scholar]
  33. Portnoy, J.M.; Barnes, C.S.; Kennedy, K. Sampling for indoor fungi. J. Allergy Clin. Immunol. 2004, 113, 189–198. [Google Scholar] [CrossRef] [PubMed]
  34. Portnoy, J.M.; Kwak, K.; Dowling, P.; VanOsdol, T.; Barnes, C. Health effects of indoor fungi. Ann. Allergy Asthma Immunol. 2005, 94, 313–319. [Google Scholar] [CrossRef] [PubMed]
  35. Cabral, J.P. Can we use indoor fungi as bioindicators of indoor air quality? Historical perspectives and open questions. Sci. Total Environ. 2010, 408, 4285–4295. [Google Scholar] [CrossRef] [PubMed]
  36. Sulaiman, I.M.; Jacobs, E.; Chatman, L.; Simpson, S.; Kerdahi, K. The First Report on Molecular Characterization of Environmental Swab Samples Collected from Compounding Center known to cause 2012 Fungal Meningitis Outbreak. In proceedings of the ASM 113th General Meeting, Denver, CO, USA, 18–21 May 2013.

Share and Cite

MDPI and ACS Style

Sulaiman, I.M.; Jacobs, E.; Simpson, S.; Kerdahi, K. Genetic Characterization of Fungi Isolated from the Environmental Swabs collected from a Compounding Center Known to Cause Multistate Meningitis Outbreak in United States Using ITS Sequencing. Pathogens 2014, 3, 732-742. https://doi.org/10.3390/pathogens3030732

AMA Style

Sulaiman IM, Jacobs E, Simpson S, Kerdahi K. Genetic Characterization of Fungi Isolated from the Environmental Swabs collected from a Compounding Center Known to Cause Multistate Meningitis Outbreak in United States Using ITS Sequencing. Pathogens. 2014; 3(3):732-742. https://doi.org/10.3390/pathogens3030732

Chicago/Turabian Style

Sulaiman, Irshad M., Emily Jacobs, Steven Simpson, and Khalil Kerdahi. 2014. "Genetic Characterization of Fungi Isolated from the Environmental Swabs collected from a Compounding Center Known to Cause Multistate Meningitis Outbreak in United States Using ITS Sequencing" Pathogens 3, no. 3: 732-742. https://doi.org/10.3390/pathogens3030732

Article Metrics

Back to TopTop